Reframing evidence generation around the patient journey

Advancing care delivery in a rapidly changing landscape

Image

Advancing care delivery

How artificial intelligence and reinforcement learning can drive equitable care

The passion behind precision health — Verily clinical pharmacist, Denise MacKenzie’s journey

 Denise MacKenzie, CDCES, Pharm D, RPh and Verily Clinical Pharmacist, who provides expert medication management services to Verily care program members.

Meet Denise MacKenzie, Verily chronic care pharmacist 

Data analysis platforms — Breaking down barriers to advance biomedical research

Breaking biomedical research barriers with a data analysis platform

8 ways Onduo virtual care optimizes diabetes management for health plan members

Optimizing diabetes management with Onduo

The passion behind precision health — Get to know endocrinologist, Dr. Neeli Singh

Dr. Neeli Singh image

Dr. Neeli Signh, MD, Onduo P.C. Medical Director and endocrinologist, who partners with Verily virtual diabetes care programs, describing how her patients motivate her to become a better diabetes provider. 

Personalizing Diabetes Care: Meet Dr. Neeli Singh, Endocrinologist at Verily

What population data could do for the individual — early warning signs with proactive monitoring

Verily Sightline — a new horizon in public health

Introducing Verily Sightline, Public health solutions for researchers, communities, and governments | Perspectives

The Verily Health Equity Center of Excellence: Addressing demographic disparities in healthcare, by design

Unlocking the Potential of GLP-1 Agonists

How Bon Secours Mercy Health transformed research finances with Verily Viewpoint Site CTMS

The passion behind precision health — Meet diabetes health coach, Marti Fernandes

diabetes health coach, Marti Fernandes

Passion behind precision health: Marti Fernandes 

Enhancing Public Health Surveillance: Wastewater Monitoring banner

Enhancing Public Health Surveillance: Wastewater Monitoring

How digital biomarkers could transform evidence generation

Innovating-healthcare-digital-biomarkers

A Verily roundtable: Innovating in healthcare with diversity by design

Innovating in healthcare with diversity by design

My journey towards accessibility

one-verily-forward

one-verily-forward-blog

Protocol digitization – What exactly is this transformative CTMS feature?

protocol-digitization-what-exactly-is-this-transformative-ctms-feature

The Role of AI in Powering Digital Protocols

Role of AI in Powering Digital Protocols

Fine-tuning LLMs to automate the digitization workflow

Solving burnout and tech overload in clinical research

Solving burnout and tech  overload in clinical research

Verily in ‘25 and beyond: powering AI for precision health

Powering AI for precision health

Stephen Gillett begins tenure as Verily CEO

Stephen-Gillette

stephen-gillett-begins-tenure-as-verily-ceo-blog

Study Watch – Another step closer to powering precision health

study-watch-another-step-closer-to-powering-precision-health-blog

Unifying One Verily

Verily’s principled approach to user-centric product design 

user-centric product design

Diabetes care management outcomes backed by peer-reviewed research

Verily Onduo study revealing type 2 diabetes outcomes

Wastewater insights from this winter's virus surge: Three takeaways from the data

Wastewater insights from this winter's virus surge

Turning water into wisdom: A history of wastewater and the insight it can provide for our communities

An infographic with an image of John Snow, a bacterium, and a wastewater treatment facility

Turning Water into Wisdom

Why research sites need an advanced clinical trial management system

research-site-banner-image

why-research-sites-need-an-advanced-clinical-trial-management-system

Verily Appoints Andrew Trister, MD, PhD as Chief Scientific Officer

Announcing Coefficient, a Verily Subsidiary Focused on Employer Stop-Loss and Backed by Swiss Re Corporate Solutions

Atlanta University Center Consortium (AUCC) provides its colleges with integrated COVID-19 testing, symptom screening and data analytics through Verily’s Healthy at Work program

Colgate-Palmolive to Leverage Verily’s Baseline Platform for Innovative Study in Oral Health Research

colgate-palmolive-to-leverage-verily-s-baseline-platform-for-innovative-study-in-oral-health-research

Bharat Rajagopal Joins Verily as Chief Revenue Officer

CRO press release

Georgiamune and Verily announce strategic partnership to advance novel cancer treatment

Granular Insurance Company (previously Coefficient Insurance Company), Verily, and Swiss Re Corporate Solutions Close Investment Transaction

granular-insurance-company-previously-coefficient-insurance-company-verily-and-swiss-re-corporate-solutions-close-investment-transaction

Highmark Health engages Verily to reinvent the healthcare experience for Highmark Health customers and clinicians

highmark-health-engages-verily-to-reinvent-the-healthcare-experience-for-highmark-health-customers-and-clinicians

Highmark Health launches diabetes management program with Onduo by Verily

highmark-health-launches-diabetes-management-program-with-onduo-by-verily

Verily and Kyverna Therapeutics announce collaboration to advance cell therapy for autoimmune diseases

Verily appoints Laura O’Donnell as General Counsel

Mayo Clinic, Verily to build advanced clinical decision support to enhance care

mayo-clinic-verily-to-build-advanced-clinical-decision-support-to-enhance-care

Morehouse College Announces $575,000 Endowed Life Sciences Scholarship from Verily

morehouse-college-announces-575-000-endowed-life-sciences-scholarship-from-verily

Myoung Cha joins Verily as Chief Product Officer 

Onduo and Fitbit collaborate to provide Onduo members with Fitbit devices and services to help manage their holistic health

Onduo by Verily and Sword Health partner to accelerate adoption of comprehensive, precision care approach

onduo-by-verily-and-sword-health-partner-to-accelerate-adoption-of-comprehensive-precision-care-approach

Onduo Data Presented at American Diabetes Association’s (ADA) 80th Scientific Sessions Highlights Meaningfully Lowered Hemoglobin A1C in People with T2D, with Significantly Greater Reductions in Participants Using Continuous Glucose Monitoring

Verily and OneOncology Announce Collaboration to Advance Cancer Research

Otsuka and Verily Expand Collaboration on Novel Clinical Trials Solutions to Accelerate Research in Major Depressive Disorder

otsuka-and-verily-expand-collaboration-on-novel-clinical-trials-solutions-to-accelerate-research-in-major-depressive-disorder

Otsuka works with Verily to launch longitudinal mental health registry to advance novel research in psychiatry

Otsuka Works with Verily to Launch Longitudinal Mental Health Registry to Advance Novel Research in Psychiatry | Verily

ResMed, Verily to Form Joint Venture to Help Reach Millions of Untreated Sleep Apnea Sufferers

resmed-verily-to-form-joint-venture-to-help-reach-millions-of-untreated-sleep-apnea-sufferers-press

Sanofi and Verily Life Sciences Announce Launch of Onduo, a Joint Venture to Develop Comprehensive Diabetes Management Platform

sanofi-and-verily-life-sciences

Verily Life Sciences Launches Liftware Level Device to Help People with Limited Hand and Arm Mobility Eat with Confidence

verily-life-sciences-launches-liftware-level-device

Gilead and Verily Announce Scientific Collaboration to Identify and Understand Immunological and Molecular Drivers of Inflammatory Diseases

Gilead-and-verily-announce-scientific-collaboration

Verily Announces $800M Investment by Temasek

verily-announces-800m-investment-by-temasek

Verily-led data and technology consortium receives $4.8M award from NIH for platform to power systems biology research across Accelerating Medicines Partnership® programs

Verily welcomes new organizations who will use Workbench to manage large biomedical datasets and accelerate research

Verily welcomes new organizationscustomers who will use Workbench to manage large biomedical datasets and accelerate research

Researchers demonstrate the potential for Verily’s Study Watch to help identify patients at risk for heart failure 

Sosei Heptares and Verily nominate first G-protein-coupled receptor target for therapeutic development

Sosei Heptares and Verily will collaborate to generate novel drug candidates against GPCR targets for immune-mediated diseases

sosei-heptares-and-verily-will-collaborate-to-generate-novel-drug-candidates-against-gpcr-targets-for-immune-mediated-diseases

The American Heart Association’s Go Red for Women and Verily’s Project Baseline Collaborate to Include More Women in Scientific Research

U.S. Centers for Disease Control and Prevention Selects Verily to Support National Wastewater Monitoring

U.S. Centers for Disease Control and Prevention selects Verily to support national wastewater monitoring

Verily Accelerates Technology and Commercial Growth with New Operations Hub in Dallas

verily-accelerates-technology-and-commercial-growth-with-new-operations-hub-in-dallas

Verily and Crohn’s & Colitis Foundation expand strategic partnership to establish novel registry of patients with inflammatory bowel disease (IBD)

verily-and-crohn-s-colitis-foundation-expand-strategic-partnership-to-establish-novel-registry-of-patients-with-inflammatory-bowel-disease-ibd

Verily and Lumea Announce Development Partnership to Advance Digital Pathology in Prostate Cancer

verily-and-lumea-announce-development-partnership-to-advance-digital-pathology-in-prostate-cancer

Verily and Swiss Re Broaden Strategic Relationship

verily-and-swiss-re-broaden-strategic-relationship

Verily Announces $1 Billion Investment Round to Fund Continued Growth and Shares Changes to Leadership Team

verily-announces-1-billion-investment-round-to-fund-continued-growth-and-shares-changes-to-leadership-team

Verily Announces $1 Billion Investment Round to Fund Growth and Innovation

Verily Announces $700 Million Investment Round to Accelerate Key Businesses, Including Baseline and Verily Health Platforms

verily-announces-700-million-investment-round-to-accelerate-key-businesses-including-baseline-and-verily-health-platforms

Verily Announces New Customers and Partners for its Healthy at Work Program

Verily Appoints Health Data Expert and Former FDA Principal Deputy Commissioner Amy Abernethy, MD, PhD as President of Verily's Clinical Research Platforms

verily-appoints-health-data-expert-and-former-fda-principal-deputy-commissioner-amy-abernethy-md-phd-as-president-of-verily-s-clinical-research-platforms

Verily Appoints Industry HR Leader Kerrie Peraino as Chief People Officer

verily-appoints-industry-hr-leader-kerrie-peraino-as-chief-people-officer

Verily Appoints Utpal Koppikar as Chief Financial Officer

verily-appoints-utpal-koppikar-as-chief-financial-officer

Verily Completes Acquisition of SignalPath, Expanding Company's Clinical Research Capabilities and Marking Company's First Major Acquisition

verily-completes-acquisition-of-signalpath-expanding-company-s-clinical-research-capabilities-and-marking-company-s-first-major-acquisition34

Verily Enhances Commercial Organization with the Appointment of Lisa Greenbaum as Chief Revenue Officer

verily-enhances-commercial-organization-with-the-appointment-of-lisa-greenbaum-as-chief-revenue-officer27

Verily Forms Strategic Alliances with Novartis, Otsuka, Pfizer and Sanofi to Transform Clinical Research

Verily introduces Lightpath, a personalized, AI-powered chronic care solution, backed by deep clinical expertise

Verily launches Baseline Health System Consortium with Vanguard Health Systems

Verily Launches Healthy at Work Program to Support Organizations In Their Efforts to Ensure a Safe Return to Work and School

Verily Opens New R&D Center in Israel Focused on the Application of AI in Healthcare

verily-opens-new-r-d-center-in-israel-focused-on-the-application-of-ai-in-healthcare

Verily Partners with Emory Healthcare to Analyze Medication and Lab Ordering Patterns for Improved Cost-Effectiveness and Operational Efficiency

Verily to Acquire SignalPath, Expanding Company's Clinical Research Capabilities

verily-to-acquire-signalpath-expanding-company-s-clinical-research-capabilities

Verily Sightline expands wastewater testing services to Europe through partnership with Bangor University in Wales

Verily launches Viewpoint Workbench to unify data and accelerate biomedical research

Walgreens Boots Alliance and Verily Announce Strategic Partnership to Innovate on New Solutions to Improve Health Outcomes

With New Name and Leader, Verily/ResMed Joint Venture Poised to Shine Light on America's Sleep Health Crisis

The ‘My Skin & Hair Journey’ registry now open for enrollment, seeking self-identifying women participants for U.S. cohort 

Perspectives

Verily in ‘25 and beyond: powering AI for precision health

Advancing care delivery in a rapidly changing landscape

What population data could do for the individual — early warning signs with proactive monitoring

Press Releases

Verily welcomes new organizations who will use Workbench to manage large biomedical datasets and accelerate research

Verily-led data and technology consortium receives $4.8M award from NIH for platform to power systems biology research across Accelerating Medicines Partnership® programs

Verily Sightline expands wastewater testing services to Europe through partnership with Bangor University in Wales

Verily introduces Lightpath, a personalized, AI-powered chronic care solution, backed by deep clinical expertise

Precision health stories

One of the smallest, most discreet Continuous Glucose Monitoring (CGM) Systems receives FDA Clearance

Data analysis platforms — Breaking down barriers to advance biomedical research

Our publications

Selective Fine-tuning on LLM-labeled Data May Reduce Reliance on Human Annotation: A Case Study Using Schedule-of-Event Table Detection

Developing composite measures that track physical activity change in people with early-stage Parkinson’s disease using machine learning and wearable sensors

Proposed framework to evaluate the ability of digital measures to track early stage Parkinson’s disease progression

More about Verily